Cyclarity Therapeutics, Inc.
Clinical trials sponsored by Cyclarity Therapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart drug UDP-003 enters first human safety tests Results expected Dec 2026 (estimated)